Optimizing Formulations for Treatment of Cryptococcal Meningoencephalitis in Sub-Saharan HIV Patients: Insights from PBPK ModelingOral presentation, GMP Symposium 2024 Eriksson J, Sjögren E, Gillon JY, Goyal V, Robinson S, Caplain H, Ribeiro I, Chenel M.Pharmetheus Affiliates Senior Director, MIDD ConsultantJohanna ErikssonSee bio Principal Director, PBPK & PBBM Scientific LeadErik SjögrenSee bio Chief Research OfficerMarylore ChenelSee bio